Vaccine Weekly articles from October 2003

Vaccine Weekly archives from October 2003

Progress in field of cancer vaccines reported.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Progress in the field of cancer vaccines has been reported in a recent issue of the journal Cellular and Molecular Life Sciences. According to a study from France, "The observation that in some...

Vaccines for parasitic and bacterial diseases in development.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Vaccines for parasitic and bacterial diseases are under development. According to recent research published in the journal Current Opinion in Immunology, "The first decade of the millennium should...

All-trans-retinoic acid improves effect of tumor vaccination.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination. "Tumor-induced immunosuppression is one of the crucial mechanisms of tumor...

Cancer vaccines present unique challenges.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Cancer vaccines present unique challenges. According to a study from the United States, "Whether vaccines are designed to prepare the immune system for the encounter with a pathogen or with cancer,...

Expression of anti-colorectal cancer polyclonal antibody library reported.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Researchers have reported the expression of a prototypic anti-colorectal cancer polyclonal antibody library in mammalian cells. "We describe the production of a prototypic polyclonal antibody...

Scientists review possibilities for contraceptive vaccines.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Scientists have published a review of contraceptive vaccines in a recent issue of Expert Opinion on Biological Therapy. According to a study from Australia, "The control of human fertility would be...

T-cell reactivity to amyloid beta increases with age.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- T-cell reactivity to amyloid beta increases with age in many people and may open avenues of therapeutic and preventive treatments for Alzheimer disease. According to published research from the...

Anthrax vaccine to be manufactured and marketed in the U.K.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- VaxGen, Inc., (VXGN) and the Health Protection Agency (HPA) for England and Wales have signed a binding letter of intent (LOI) to negotiate terms under which VaxGen would license U.K. rights to, and...

Adults fail to follow flu vaccine guidelines.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Adults with asthma are considered a high-risk group for developing complications after contracting the influenza virus, yet the majority of adults with asthma do not receive an annual influenza...

Joint venture wins $11M award to expedite production of botulinum vaccine.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Computer Sciences Corporation (CSC) announced that DynPort Vaccine Company LLC (DVC), a joint venture between CSC and Porton International, Inc., has been awarded an $11 million grant from the National...

U.S. firm to develop new botulinum vaccine.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- A Frederick, Maryland, pharmaceutical firm has received an $11 million federal grant to develop a vaccine against the botulinum bacteria, which can produce the deadliest naturally occurring toxin known...

Data from Theratope vaccine trial to be presented at breast cancer symposium.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Biomira, Inc., (BIOM, BRA) announced that data from the final analysis of its Theratope vaccine phase III clinical trial in metastatic breast cancer will be presented at the 26th Annual San Antonio...

HPV-16-transformed cells expressing herpes thymidine kinase induce immunity.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Immunization with live HPV-16-transformed mouse cells expressing the herpes simplex thymidine kinase and either granulocyte-macrophage colony stimulating factor (GM-CSF) or interleukin-2 (IL-2) had...

Immunization in tumor prevention reviewed.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Researchers have published a review of immunization for tumor prevention in the journal International Immunopharmacology. According to a study from Italy, "Recent experimental data suggest that...

DNA vaccination may be the answer to stable, protective T-cell memory.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- DNA vaccination may be the answer to stable, protective T-cell memory. "Distinct populations of both CD4+ and CD8+ memory T cells have been identified on the basis of their location (lymphoid versus...

Gates Foundation commits $55 million for research.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- The Bill and Melinda Gates Foundation has announced it will give $55 million to help develop a vaccine to prevent dengue and dengue hemorrhagic fever, an increasing problem in developing countries. ...

Progress reported in development of new drug delivery device portfolio.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Antares Pharma, Inc., (ANTR) announced that it has completed preliminary clinical testing on several of its new device products, and these devices are now available for licensing for use with specific...

Review of progress in treating Ebola virus published.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- A review of the progress in treating Ebola virus infection has been published in Nature Reviews Immunology. According to a study from Canada, "Ebola virus, being highly pathogenic for humans and...

Recombinant vaccines against Japanese encephalitis developed.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Researchers have developed recombinant vaccines against Japanese encephalitis. "Japanese encephalitis (JE) is the major form of viral encephalitis in much of the South-East Asia, India, and China....

Dawson James Securities initiates coverage of HIV vaccine developer.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Robert Wasserman, director of Research for Dawson James Securities, a division of ViewTrade Financial, has initiated coverage on Immune Response Corporation (IMNR) with a buy rating and a 12-month price...

Intestinal cell cycle dysregulation occurs during SIV infection.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- High-throughput gene expression profiling indicates dysregulation of intestinal cell cycle mediators and growth factors during primary simian immunodeficiency virus infection. According to a study...

Prevalence of hepatitis B infection high in HIV-infected subjects.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- The prevalence of hepatitis B infection is high in HIV-infected subjects. According to published research from the United States, "We determined incidence and risk factors for acute and chronic...

Scientists announce vaccine hope.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Vaccines could be used alongside conventional treatments to combat certain forms of cancer, scientists suggest. A Cancer Research UK scientist and his team have found that a vaccine targeted...

Cancer, parasitic, and viral disease vaccine has positive first stage results.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- PrimaBioMed Limited, a cancer and immunotherapy research and therapeutic development company, announced positive results from the first stage of development of its subsidiary Panvax's DCtag vaccine...

Electroporation company secures rights to Interleukin-12.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Ichor Medical Systems, Inc., announced that it has licensed worldwide rights to the Interleukin-12 (IL-12) gene from The Wistar Institute, Philadelphia, Pennsylvania. Ichor plans to develop...

AIDS, malaria, and TB greatest threats to human security, official says at UN.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- There is no greater threat to individual human security than HIV/AIDS, malaria, and tuberculosis, a senior official of the Global Fund set up to help combat those illnesses said recently at a briefing...

Needle-free flu vaccine unveiled.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- MedImmune, Inc. is launching the first needle-free flu vaccine this fall with an aggressive advertising campaign aimed at convincing consumers they can't afford to get sick. The 9-week print and TV...

Poor uptake of influenza vaccine in patients receiving cytotoxic chemotherapy.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Poor uptake of influenza vaccinations has been reported in patients receiving cytotoxic chemotherapy. According to published research from England, "This audit was designed to assess whether...

Distribution agreement inked for AGRO-JET needle-free injectors in Japan.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Medical International Technology, Inc., (MDIR), a developer and marketer of patented needle-free jet injectors for human and animal inoculation, announced that its MIT Canada subsidiary has signed a...

Partial clinical hold on phase III trials of cancer vaccine Oncophage.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Antigenics, Inc., (AGEN) announced that it had completed a meeting with the U.S. Food and Drug Administration (FDA) on product characterization issues. Following a discussion of the company's...

NIAID launches malaria vaccine trial in Africa.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- The National Institute of Allergy and Infectious Diseases (NIAID), one of the U.S. National Institutes of Health, has reached a milestone in its efforts to support accelerated development of malaria...

Positive, long-term, follow-up data reported from phase I trial of GVAX.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Cell Genesys, Inc., (CEGE) reported long-term follow-up data from a phase I clinical trial of GVAX melanoma vaccine, a patient-specific vaccine made directly from patient tumor biopsies. Data from...

Haemophilus influenzae type b disease increasing in vaccinated children.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Haemophilus influenzae type b disease is increasing among vaccinated children in the U.K. "In October 1992, Haemophilus influenzae type b (Hib) conjugate vaccine was introduced to infants in the...

Two parasites' genes sequenced.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Two groups have reported on the sequencing and analysis of most of the genes found in two of the parasites that cause schistosomiasis, a significant cause of morbidity and mortality in the developing...

Tetanus vaccine shortage causing problems in the United States.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- A shortage of tetanus vaccines in the United States is causing problems for emergency departments. "The purpose of this study is to determine the effect of the tetanus immunization shortage on...

Update provided on HIV, cancer vaccines, workforce reduction.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Epimmune, Inc., (EPMN) provided an update of its three ongoing clinical trials in HIV, lung cancer, and colorectal cancer, and the company announced a workforce reduction aimed at focusing its resources...

Production of recombinant botulinum protein vaccine candidate reported.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Researchers have produced a recombinant protein vaccine candidate using the botulinum neurotoxin heavy chain fragment. "Structural conversion of the serotype A recombinant botulinum neurotoxin...

Update on epitope-based vaccines published.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- An update on epitope identification, and vaccine design and delivery has been published in a recent issue of Current Opinion in Immunology. "The basic premise of the epitope-based approach to...

Deal signed to share development of West Nile virus hyperimmune globulin.
October 1, 2003... 2003 OCT 1 - (NewsRx.com & NewsRx.net) -- Cangene has entered a collaborative research and development agreement with Acambis plc to develop and manufacture a hyperimmune globulin for treating and preventing infection by West Nile virus (West...

DNA immunization enhances immune response to fowlpox-based SIVmac vaccine.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- Prior DNA immunization enhances immune response to dominant and subdominant viral epitopes induced by a fowlpox-based SIVmac vaccine in long-term slow-progressor macaques infected with SIVmac251. ...

Lung cancer vaccines yield promising results in clinical trials.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- Lung cancer vaccines are yielding promising results in clinical trials. "A number of cancer vaccine and gene therapy approaches are being evaluated in patients with lung cancer. Cancer vaccine...

AIDS vaccine protects against infection in a macaque AIDS model.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- A single DNA priming followed by a single booster with a recombinant replication-defective Sendai virus vector was protective in a macaque AIDS model. According to a study from Japan, "We previously...

Peptide epitopes from herpes simplex virus glycoprotein confer immunity.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- Novel immunodominant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity have been identified. "The molecular characterization of the...

Novel vaccine strategies reported with Streptococcus pneumoniae antigens.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- Novel vaccine strategies with protein antigens of Streptococcus pneumoniae have been reported recently. According to a study from the United States, "Infections caused by Streptococcus pneumoniae...

Recent developments in West Nile virus vaccine reported.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- Recent developments in West Nile virus vaccines and antiviral therapy have been reported in a recent issue of Expert Opinion on Therapeutic Patents. "West Nile virus (WNV) is a mosquito-borne...

Smallpox vaccines may protect against HIV.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- Smallpox vaccinations may also provide protection against the virus that causes AIDS, according to researchers at George Mason University. The findings are only preliminary and based on a very small...

Incyte enters licensing agreement for a phase II HIV drug.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- Incyte Corp. (INCY) and Pharmasset, Ltd., announced that they have entered into a collaborative licensing agreement to develop and commercialize the antiretroviral drug Reverset, also known as RVT,...

Study: Patients can benefit from simplified antiretroviral treatments.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- A large study shows that simplified antiretroviral treatment regimens containing Viramune (nevirapine) or efavirenz offer comparable efficacy and safety in patients who switched from a protease...

New research in allergic inflammation and anti-IgE therapy unveiled.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- New research on allergic diseases and patient care was released at the World Allergy Organization's (WAO) Congress in Vancouver, Canada, which took place September 6-12, 2003. Respiratory allergies...

GeneMax Corp. announces agreement for the production of TAP cancer vaccine.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- GeneMax Corp. (GMXX) announced an amended contractual agreement with Molecular Medicine BioServices, Inc., of San Diego, California, for the production of its clinical vector for delivery of the TAP...

Epimmune earns milestone payment under cancer epitope license.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- Epimmune, Inc., (EPMN) announced that it has earned and received a milestone payment from Anosys, Inc., as a result of Anosys' filing of an IND for a product incorporating Epimmune technology under a...

FDA approves clinical trial to test therapeutic vaccine Collidem.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- IDM (Immuno-Designed Molecules), a biopharmaceutical company in the field of cellular immunotherapy, announced that it has received approval from the U.S. Food and Drug Administration (FDA) to launch a...

"Forgotten" malaria still kills millions.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- Shivering and sweating feverishly, Felicia Egbuchue took the malaria medicine her doctor prescribed. Although it had cured her in years past, this time it didn't. She was rushed to the hospital, and...

Genetically enhanced bacteria may prevent HIV infections in women.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- Researchers at the Stanford University School of Medicine have found in laboratory experiments that bacteria that naturally live in the body can be genetically enhanced for potent antiviral activity,...

Successful negotiations by Zimbabwean women increase male condom use.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- Researchers have identified successful negotiation strategies used by Zimbabwean women to increase the use of male condoms. According to a study from the United States, "One of the fundamental...

Hepatitis vaccine approved for sale in Argentina.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- Corixa Corporation (CRXA) announced the Argentinean approval of Supervax, Berna Biotech's prophylactic vaccine containing Corixa's synthetic RC-529 adjuvant, for the prevention of Hepatitis B infection....

Corixa Corp. signs research, development, and license agreement.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- InNexus Biotechnology, Inc., (IXS), a monoclonal antibody-development company, and Corixa Corp. (CRXA), a developer of immunotherapeutic products, announced that the companies have entered into an...

Multiple T cell subsets control Francisella tularensis growth.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- Multiple T cell subsets control Francisella tularensis live vaccine strain intracellular growth without stimulation through macrophage interferon gamma receptors. According to a study from the...

Scientists invent search-and-destroy method to flush HIV out of hiding places.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- University of California Los Angeles AIDS Institute scientists have devised a new technique to switch on and drive hibernating HIV from its hiding places in the body. Reported in Immunity, the...

Adults with asthma fail to follow flu vaccine guidelines.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- Adults with asthma are considered a high risk group for developing complications after contracting the influenza virus, yet the majority of adults with asthma does not receive an annual influenza...

Measles outbreak reported in a suburb of Tokyo in 1998-1999.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- A measles outbreak occurred in a suburb of Tokyo, Japan, in 1998-1999. According to recent research published in the Scandinavian Journal of Infectious Diseases, "A 1998-1999 outbreak of measles in...

Phase II study demonstrates vaccine effectiveness in half of patients.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- A Phase II clinical study reports that administration of a prototype vaccine, developed by Therion Biologics Corp., administered in combination with interleukin-2 (IL-2), generated objective tumor...

Systemic treatment for advanced melanoma reviewed.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- Researchers have reviewed systemic treatments for advanced melanoma in a recent issue of the journal Onkologie. According to recent research from Germany, "Malignant melanoma is a tumor of...

Immunotherapeutic approaches in ovarian cancer reviewed.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- Immunologic principles and immunotherapeutic approaches in ovarian cancer have been reviewed in a recent issue of Hematology - Oncology Clinics of North America. According to researchers in the...

Financing secured for the development of cancer vaccines.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- Therion Biologics Corporation has successfully secured private equity financing totaling $39 million for the advanced clinical development of Panvac-VF and Prostvac-VF, its lead vaccine candidates to...

Horizon BCBS to educate parents about infant immunizations.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- Horizon Blue Cross Blue Shield of New Jersey (Horizon BCBSNJ) announced an immunization reminder program to help educate new parents about crucial vaccinations for their infant children. New...

Haemophilus influenzae antibodies present in vaccinated infants.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- Antibodies to Haemophilus influenzae type b polysaccharide canonical variable regions are present in vaccinated infants. According to recent research published in the journal Clinical Immunology,...

Bordetella pertussis isolates in Russia compared to vaccine strains.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- Researchers have published a comparison of the Bordetella pertussis and B. parapertussis isolates circulating in Saint Petersburg between 1998 and 2000 with Russian vaccine strains in the Journal of...

Virulent highly divergent vaccine-derived polioviruses circulating.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- Researchers have found evidence of the circulation of virulent highly divergent vaccine-derived polioviruses. According to a study from the United States and Russia, "Two approaches based on...

$85 Million awarded for research on human immunity and biodefense.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- A better understanding of the human immune response to potential agents of bioterror and rapid development of countermeasures such as vaccines and therapies are among the objectives of a new program...

Researchers continue AIDS vaccine research with $15 million grant.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- A team of medical researchers from three Seattle research facilities recently received a grant of more than $15 million from the National Institute of Allergy and Infectious Diseases (NIAID) to continue...

Licensing deal signed with Gilead Sciences for smallpox drug.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- Chimerix, Inc., an emerging biotechnology company developing orally available, targeted medicines from bioactive molecules, announced that it has licensed rights from Gilead Sciences, Inc., (GILD) to...

SBIR grant awarded to develop anti-smallpox therapeutics.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- Aphios Corporation has been awarded a phase I Small Business Innovative Research (SBIR) grant for the "Development of Novel Anti-Smallpox Therapeutics from Marine Microorganisms," from the National...

Modes of protection against infection shared by smallpox vaccine viruses.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- Researchers report shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses. "The concern about bioterrorism with smallpox has raised the...

New generation of cell culture assay for smallpox vaccine potency developed.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- Researchers have developed a new generation of cell culture assay for smallpox vaccine potency. According to a study from France, "The potency of smallpox vaccines produced in the 1970s was tested...

Company successfully completes StaphVAX immunogenicity study.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- Nabi Biopharmaceuticals (NABI) announced the successful completion of an immunogenicity trial using material from the lot of StaphVAX (Staphylococcus aureus Polysaccharide Conjugate Vaccine) intended...

New vaccine reduces antibiotic-resistant infections and protects families.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- A new vaccine introduced nearly 3 years ago has been shown to be effective in reducing antibiotic resistance pneumococcal disease for all ages, particularly for children under 2 years old, according to...

IL-4 exerts differential effects in peptide-induced autoimmunity.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- Interleukin (IL)-4 exerts differential effects in peptide-induced autoimmunity. According to recent research published in the journal Clinical Immunology, "BALB/c mice immunized with multimeric...

Study evaluates "rabbit fever" as part of biodefense research plan.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- Since September 11, rabbits have taken on a whole new meaning for biodefense researchers at the University of Missouri-Columbia, who are trying to unravel the science behind rabbit fever, also known as...

Haemophilus influenzae isolated from children with vaccine failures.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- Researchers have reported the molecular epidemiology of Haemophilus influenzae type b isolated from children with clinical cases of conjugate vaccine failures. "We analyzed eight invasive...

Facts and speculation on vaccine safety reviewed.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- The facts and speculation on the safety of vaccines have been reviewed in a recent issue of Medecine Et Maladies Infectieuses. According to a study from France, "The very high standards for the...

CDC: Chickenpox rates drop in 4 states.
October 8, 2003... 2003 OCT 8 - (NewsRx.com & NewsRx.net) -- The number of chickenpox cases in four states dropped more than 75% as inoculations became more common in the last decade, according to a new federal study. The total number of cases in Illinois,...

HIV-1 peptide protects mice against virus expressing HIV-1 antigen.
October 15, 2003... 2003 OCT 15 - (NewsRx.com & NewsRx.net) -- An epitope-enhanced conserved HIV-1 peptide protected HLA-A2-transgenic mice against virus expressing HIV-1 antigen. "HIV epitopes may have developed to be poor immunogens. As a counterapproach...

Plasmodium falciparum antigens identified.
October 15, 2003... 2003 OCT 15 - (NewsRx.com & NewsRx.net) -- Researchers have identified Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data. "The recent explosion in genomic sequencing has made available a wealth of data that...